Biocept Stock

Biocept Stocks

The The number of shares of Biocept (BIOCQ) as of Mar 3, 2026 is 570,000. In the previous year, The number of shares was 570,000 — a change of 0% (lower).

Stocks

570,000

YoY

0%

Last updated: Mar 3, 2026

In 2026, Biocept had 570,000 outstanding stocks, a 0% change from the 570,000 stocks in the previous year.

The Biocept Stocks history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

NUMBER OF STOCKS (k USD)
Date
NUMBER OF STOCKS (k USD)
Jan 1, 2011
570 base
Jan 1, 2012
570 base
Jan 1, 2013
570 base
Jan 1, 2014
570 base
Jan 1, 2015
570 base
Jan 1, 2016
570 base
Jan 1, 2017
570 base
Jan 1, 2018
10 base
Jan 1, 2019
70 base
Jan 1, 2020
390 base
Jan 1, 2021
490 base
Jan 1, 2022
570 base
Invalid Date
570 base
Invalid Date
570 base
Invalid Date
570 base
YEARNUMBER OF STOCKS (k USD)
2025 est 570
2024 est 570
2023 est 570
2022 570
2021 490
2020 390
2019 70
2018 10
2017 570
2016 570
2015 570
2014 570
2013 570
2012 570
2011 570

Unlock the full history with 30+ years of data and forecast estimates.

Unlock all data — PRO

Biocept Shares Outstanding

Biocept shares outstanding

The number of shares was Biocept in 2025 — This indicates how many shares 570,000 is divided into. Since shareholders are the owners of a company, each share represents a small portion of the company's ownership.
  • 3 Years

  • 5 Years

  • 10 Years

  • 25 Years

  • Max

Number of stocks
Details
Date
Number of stocks
Jan 1, 2011
0 base_Shares
Jan 1, 2012
0 base_Shares
Jan 1, 2013
0 base_Shares
Jan 1, 2014
0 base_Shares
Jan 1, 2015
0 base_Shares
Jan 1, 2016
0 base_Shares
Jan 1, 2017
0 base_Shares
Jan 1, 2018
10,000 base_Shares
Jan 1, 2019
70,000 base_Shares
Jan 1, 2020
390,000 base_Shares
Jan 1, 2021
490,000 base_Shares
Jan 1, 2022
570,000 base_Shares
Invalid Date
570,000 base_Shares
Invalid Date
570,000 base_Shares
Invalid Date
570,000 base_Shares

Biocept Stock analysis

What does Biocept do? Biocept is one of the most popular companies on Eulerpool.com.

Stocks Details

Evaluating Biocept's Shares Outstanding

Biocept's shares outstanding refer to the total number of shares that are currently held by all its shareholders, including institutional investors and restricted shares held by the company’s officers and insiders. The number of shares outstanding is crucial in determining the company's market capitalization and is used by investors to assess the company’s size, financial health, and investment potential.

Year-to-Year Comparison

Tracking the changes in Biocept’s shares outstanding over the years can provide investors with insights into the company's financial strategies and market valuation. An increase in shares outstanding can result from actions like issuing new shares, while a decrease can result from buybacks.

Impact on Investments

For investors, understanding Biocept’s shares outstanding is essential for evaluating its earnings per share (EPS) and market valuation. A change in the number of shares outstanding can impact the EPS, which is a significant driver of stock prices and investor decisions.

Interpreting Changes in Shares Outstanding

Variances in Biocept’s shares outstanding can signal shifts in the company’s financial strategy. An increase may dilute the EPS and share value, indicating potential fundraising or acquisitions. Conversely, a decrease, often due to share buybacks, can enhance share value and indicate the company’s confidence in its financial performance.

Frequently Asked Questions about Biocept stock

The number of shares of Biocept amounted to 570,000 570,000

Other — Biocept

Stock savings plans offer an attractive way for investors to build wealth over the long term. One of the main advantages is the so-called cost-average effect: by regularly investing a fixed amount in stocks or stock funds, you automatically buy more shares when prices are low, and fewer when they are high. This can lead to a more favorable average price per share over time. In addition, stock savings plans allow small investors access to expensive stocks, as they can participate with small amounts. Regular investment also promotes a disciplined investment strategy and helps to avoid emotional decisions, such as impulsive buying or selling. Furthermore, investors benefit from the potential appreciation of the stocks as well as from dividend distributions, which can be reinvested, enhancing the compounding effect and thus the growth of the invested capital.

All Key Metrics — Biocept